HUTCHMED (China) (HMDCF) Common Equity (2014 - 2026)

HUTCHMED (China) (HMDCF) has reported Common Equity for 13 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity rose 2.66% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 2.66% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, changed N/A from the prior year.
• Common Equity was $1.3 billion for Q2 2026 at HUTCHMED (China), up from $1.3 billion in the prior quarter.
• Over five years, Common Equity peaked at $1.3 billion in Q2 2026 and troughed at $636.9 million in Q4 2022.
• A 5-year average of $972.7 million and a median of $851.8 million in 2022 frame the typical range for Common Equity.
• Across the five-year window, Common Equity tumbled 38.73% in 2022 and surged 65.15% in 2025, its largest moves.
• Over 5 years, Common Equity stood at $636.9 million in 2022, then rose by 25.62% to $800.0 million in 2023, then declined by 6.0% to $752.0 million in 2024, then jumped by 66.39% to $1.3 billion in 2025, then advanced by 1.89% to $1.3 billion in 2026.
• The last three Common Equity figures came in at $1.3 billion (Q2 2026), $1.3 billion (Q4 2025), and $1.2 billion (Q2 2025), per Business Quant data.